CBFA2T3 and acute myeloid leukemia: CBFA2T3-GLIS2 fusion characterizes an AML subtype exclusive to pediatrics, accounting for approximately 5% of all pediatric AML and primarily found in non-DS AMKL in infants and AML in early childhood, with most patients age < 5 years [130,133,134].